Atorvastatin Calcium Tablet
Product Images NDC 50090-5632

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)
Chemical structure of Atorvastatin Calcium, depicting the molecular arrangement including two atorvastatin molecules complexed with calcium and three water molecules (Ca2+ ยท 3H2O). The structure shows detailed rings and functional groups characteristic of atorvastatin.*
FDA Label Image

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)
A cumulative incidence line graph comparing Atorvastatin and placebo over 3.5 years. The x-axis represents time in years, and the y-axis shows cumulative incidence percentage. Two curves illustrate lower cumulative incidence for Atorvastatin compared to placebo, with a hazard ratio (HR) of 0.64 and a p-value less than 0.0005.*
FDA Label Image

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)
A cumulative hazard plot showing the time to first primary endpoint over four years of follow-up comparing Atorvastatin to placebo. The graph displays cumulative hazard percentage on the y-axis and time in years on the x-axis, illustrating lower hazard with Atorvastatin compared to placebo.*
FDA Label Image

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over five years for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. Atorvastatin 10 mg shows a slightly higher event rate than 80 mg over time.*
FDA Label Image

Label Image (Lbl500905632)

Label Image (Lbl500905632)
Atorvastatin Calcium 40 mg oral tablets packaged by A-S Medication Solutions. The white label displays the product name, strength, and quantity of 30 tablets. Each film-coated tablet contains atorvastatin calcium equivalent to 40 mg atorvastatin. Storage instructions indicate to store at 77 degrees Fahrenheit. The label includes a product NDC 50090-5632 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.